Spatially-resolved Brillouin spectroscopy reveals biomechanical changes
  in early ectatic corneal disease and post-crosslinking in vivo by Shao, Peng et al.
 1 
Title: Spatially-resolved Brillouin spectroscopy reveals biomechanical changes in early ectatic 
corneal disease and post-crosslinking in vivo 
 
Authors: Peng Shao1†, Amira M. Eltony1†, Theo G. Seiler1,3,4, Behrouz Tavakol1, Roberto 
Pineda2, Tobias Koller3, Theo Seiler3*, Seok-Hyun Yun1,5** 
1 Harvard Medical School and Wellman Center for Photomedicine, Massachusetts 
General Hospital, Boston, MA 02114, USA 
2 Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA 
3 Institute for Refractive and Ophthalmic Surgery (IROC), Zürich 8002, Switzerland 
4 Universitätsklinik für Augenheilkunde, Inselspital, Bern 3010, Switzerland 
5 Harvard-MIT Health Sciences and Technology, Cambridge, MA 02139, USA 
† equal contribution 
* theo@seiler.tv, ** syun@hms.harvard.edu 
 
 
Abstract: Mounting evidence connects the biomechanical properties of tissues to the 
development of eye diseases such as keratoconus, a common disease in which the cornea thins 
and bulges into a conical shape. However, measuring biomechanical changes in vivo with 
sufficient sensitivity for disease detection has proved challenging. Here, we present a first large-
scale study (~200 subjects, including normal and keratoconus patients) using Brillouin light-
scattering microscopy to measure longitudinal modulus in corneal tissues with high sensitivity 
and spatial resolution. Our results in vivo provide evidence of biomechanical inhomogeneity at 
the onset of keratoconus and suggest that biomechanical asymmetry between the left and right 
eyes may presage disease development. We additionally measure the stiffening effect of corneal 
crosslinking treatment in vivo for the first time. Our results demonstrate the promise of Brillouin 
microscopy for diagnosis and treatment of keratoconus, and potentially other diseases. 
 
INTRODUCTION 
In parts of the eye, mechanical structure and function are closely linked. The cornea is a prime 
example; to maintain the prolate configuration that is critical for good vision, the cornea should 
have adequate mechanical stiffness to counteract external mechanical stresses such as in-plane 
tension and intraocular pressure (IOP)1. Mounting evidence suggests that the biomechanical 
properties of ocular tissues can be diagnostic targets due to their association with various eye 
diseases and refractive errors2. The mechanical properties of the cornea stem from the intricate 
lattice of macromolecules such as collagen fibers and proteoglycans making up the corneal 
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stroma3,4. Disintegration of the structural organization alters the biomechanical properties and 
shifts mechanical homeostasis, which, if severe and focal, can result in corneal pathology and 
impair vision5,6. 
Keratoconus (KC) is a common disease in which the normal prolate cornea locally thins and 
bulges into a conical shape7. Its etiology is not fully understood, but numerous experimental 
studies have suggested the importance of biomechanical interactions: genetic and molecular 
studies revealed links to the disintegration of collagen extracellular matrix8, through increase of 
matrix metalloproteinase9 and decrease of lysyl oxidase activity10; eye rubbing, a proven risk 
factor for KC, has been shown to elevate the tear concentration of protease11; disrupted collagen 
orientation12–14 and reduced mechanical moduli1 have been observed in KC explants and corneas 
that developed ectasia after laser-assisted in situ keratomileusis (LASIK). 
Current diagnosis of KC is primarily focused on detecting abnormal morphological features in 
thickness and curvature. Advances in pachymetry and topography have greatly improved the 
diagnosis and treatment monitoring of KC. However, the current morphological criteria do not 
allow physicians to predict the rate of progression of KC, a critical input for planning optimal 
treatment. Early-stage KC prior to the appearance of definitive morphological abnormality is 
considered a major risk factor for post refractive-surgery ectasia15,16. However, detecting such 
subclinical or forme fruste KC remains an elusive goal. These continuing unmet clinical needs 
have motivated scientists to look for more sophisticated morphology-based metrics, specific 
genetic and molecular markers, and other diagnostic approaches such as corneal 
biomechanics2,17. 
Interestingly, corneal biomechanics has already been embraced in the treatment of KC. Corneal 
crosslinking (CXL) is the current standard to treat mild and moderate KC. CXL aims to reinforce 
the three-dimensional macromolecular organization consisting of collagen and proteoglycans and 
thereby stiffen the cornea18. CXL has proven to be clinically effective in most cases, capable of 
arresting further thinning and protrusion and even improving vision through keratometric 
flattening of the cones19–24. Definitive diagnosis of progressive KC in early stages is critical to 
achieve optimal therapeutic results25. Unfortunately, because current diagnostics cannot 
differentiate progressive versus non-progressive KC, physicians rely on repeated measurements 
over several months to monitor the progression of morphological features, often at the risk of 
having suboptimal therapeutic outcomes due to delayed treatment26. 
With compelling reasons to develop biomechanics-based diagnostics, scientists have devised 
noninvasive tools capable of measuring biomechanical parameters in patients17. Recently, two 
commercial instruments, the ocular response analyzer (ORA, Reichert Technologies Inc., USA) 
and the corneal visualization Scheimpflug technology (Corvis ST, OCULUS Optikgeräte GmbH, 
Germany), became available, which use a single air-puff to induce millimeter-scale deformation 
of the cornea and extract various viscoelastic parameters27. Numerous clinical studies have 
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demonstrated the potential of the technique for cases of moderate to severe KC28–35. However, 
the studies also revealed limitations of the current instruments in identifying mild and moderate 
KC28,29. The rather disappointing results so far are attributed to the fact that corneal deformation 
is inherently dependent on IOP and the anatomical geometry of the connective tissue shell 
making up the eye, including both cornea and sclera36. More sophisticated computational 
methods are being sought to deal with the compounding factors and to discern subtle differences 
in biomechanical properties with improved sensitivity and accuracy35,37,38. Another drawback of 
the air-puff technique is that it measures overall corneal stiffness so would be less sensitive to 
focal changes in a specific region of the cornea. In research laboratories, other promising 
techniques are under development, such as optical coherence elastography39–42 using various 
external stimuli43–48. However, their safety and feasibility in vivo has yet to be tested. 
We have previously demonstrated Brillouin light-scattering microscopy, which makes it possible 
to measure longitudinal mechanical modulus in tissues49. Unlike air-puff-based methods, the 
technology does not involve corneal deformation and can interrogate a specific region and depth 
in corneal tissue with optical resolution50. We have established the safety of this technology in 
humans and reported Brillouin elasticity maps of corneas in advanced KC patients, providing in 
vivo evidence of spatially heterogeneous, biomechanical weakening in late-stage KC corneas51. 
In this paper, we describe the largest clinical Brillouin studies to date, focusing on the early 
stages of KC. To detect subtle biomechanical changes in mild and moderate KC, we improved 
the measurement sensitivity and repeatability of Brillouin systems. A careful analysis of 
Brillouin frequency shifts measured in vivo led to several findings about previously unknown, 
biomechanical features in KC corneas and corneas after CXL treatment, as well as normal 
corneas. We present results that point to promising diagnostic metrics based on spatially-
resolved biomechanical measurements. 
 
RESULTS 
Development of in vivo Brillouin microscopes 
We have built two Brillouin microscopes with nearly identical optical designs. One tabletop 
system was used for studies at MGH in Boston (Fig. 1A). The other rack-mounted system was 
built at MGH and shipped to Zürich for studies at IROC (Fig. 1B). Compared to our previous 
instruments51, the new systems have several hardware and software upgrades to improve 
measurement sensitivity, stability and eye tracking, as well as mechanical robustness. Each 
system consists of a light source, human interface, spectrometer, and computer (Fig. 1C). The 
light source is a single-frequency tunable laser with its output spectrum locked to a near-infrared 
wavelength of ~780 nm and filtered using an etalon52. The laser light is coupled via a 
polarization-maintaining fiber to the human interface, in which polarization optics route the laser 
beam to the eye and direct backscattered light to a single-mode fiber. The spectrometer employs 
two-stage VIPA etalons and apodization filters to achieve a free-spectral range (FSR) of 16 GHz, 
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a resolution of ~120 MHz, and an extinction efficiency of –65 dB. The optical power on the 
cornea is 3-5 mW (Fig. 1D), which is several times lower than the maximum permissible 
exposure level according to American National Standard Institutes (ANSI) guidelines 
(Supplementary Information). With this optical power applied to corneal tissues, an electron 
multiplying charge-coupled device (EMCCD) camera recorded a total of ~6,000 Brillouin 
photons per second. The Brillouin frequency shift, which is half the frequency difference 
between the Stokes and Anti-Stokes spectral peaks, is determined by curve fitting the recorded 
Brillouin spectra (Figs. 1E and S2). With an EMCCD integration time of 0.2 s, we obtained a 
shot-noise-limited sensitivity of ~ ± 8 MHz in Brillouin frequency shift measurement (Fig. S4). 
The spatial resolution was measured to be ~5 and 30 µm in the transverse and axial directions, 
respectively (Fig. S5). The system employs temperature sensors and temperature-calibrated 
reference materials to attain short- and long-term repeatability of ~ ± 10 MHz (Fig. S7). For 
corneal scans, an operator adjusts the human interface using a manual joystick to locate the focus 
at a desired location in front of the cornea while monitoring an eye-tracking video camera based 
on pupil detection (Fig. 1F). At each location, the operator starts a motorized axial scan to obtain 
a depth profile and calculate the mean Brillouin shift over the stroma (Fig. 1G). A typical 2D 
Brillouin elasticity map constructed from the mean Brillouin shifts measured at various scan 
locations using standard spatial interpolation is shown in Fig. 1H. Please refer to Materials and 
Methods and Supplementary Information for more technical details of the systems and data 
acquisition.  
 
Brillouin analysis of normal corneas in vivo 
To establish a baseline for the normal population, we scanned healthy subjects with corneal 
thickness in a normal range of 495 to 600 µm, no irregular astigmatism, and no history of 
ophthalmic pathology or surgery. For each subject, a mean central Brillouin shift was obtained 
from 5 axial scans in a central region within a 2-mm radius from the pupil center. The measured 
values from 47 healthy subjects (age: 39 ± 13 y/o, 51% female, one eye per subject with 
left/right chosen at random) ranged from 5.69 to 5.76 GHz with a standard deviation (SD) of 24 
MHz. When analyzed as a function of age (Fig. 2A), the Brillouin shift values tend to increase 
with age at a nominal slope of ~3 MHz per decade, but the correlation was not statistically 
significant. 37 of the 47 subjects had both of their eyes scanned. The mean Brillouin shifts were 
nearly identical within the instrument’s resolution for the left and right eyes: 5.721 ± 0.017 
versus 5.723 ± 0.017 GHz (Fig. 2B). The difference between the left and right eyes of each 
individual subject makes a narrow, Gaussian-like distribution centered at 1.8 MHz (mean) (Fig. 
2C). The bilateral symmetry between the two eyes of healthy subjects is remarkable and in 
contrast with the large interpersonal variability of ± 24 MHz. 
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Brillouin measurements of keratoconus patients at different stages of severity 
To investigate KC, subjects were scanned who have been diagnosed with KC by corneal 
specialists. The patients were grouped into 4 stages of severity according to the Amsler-
Krumeich classification53 using quantitative criteria, namely refractive error, best spectacle-
corrected visual acuity, minimum corneal thickness, and maximum curvature (K-max). For each 
cornea, pachymetry and topography images identified a “cone” region, which we define as the 
area within a 1 mm radius from the thinnest point. Brillouin scans were conducted at 20 to 40 
lateral locations to generate a Brillouin map of the cornea. A few representative Brillouin maps 
are shown in Fig. 3, comparison to Brillouin maps of normal corneas (Fig. 3A). For advanced 
KC corneas in stage III or IV, Brillouin maps showed considerable non-uniformity compared to 
normal corneas (Fig. 3C). The cones, defined herein by the thinnest points, are approximately 
coincident with the bulging areas of abnormal curvature and surface elevation, and these areas 
are characterized by low Brillouin frequency shift values, distinctly different by as much as 100-
200 MHz compared to healthy corneas. Stage-I corneas are characterized by mild morphological 
anomalies, and the thinnest points do not always overlap with the locations of maximum 
curvature or posterior elevation. Compared to stage-III-IV cases, state-I corneas exhibit much 
more uniform Brillouin maps, and the regions of lower Brillouin values are less pronounced 
(Fig. 3B). 
The locations of minimum thickness, i.e. cone centers, are distributed predominantly in the 
center-temporal region (Fig. 4A). The XY coordinate in mm of the center of the distribution was 
(0.45, –0.85) for stages I and II (n=34, 36 ± 11 y/o, 47% female) and (0.48, –1.2) for stages III 
and IV (n=12, 46 ± 14 y/o, 75% female). The data suggest that the cone location within an 
individual may not change much as KC progresses. From the Brillouin maps, we calculated the 
mean Brillouin frequency shifts in the cone regions and plotted the data as a function of 
minimum corneal thickness (Fig. 4B) and maximum anterior sagittal curvature, K max (Fig. 
4C). Weak to moderate trends of decreasing Brillouin frequency shifts with increasing KC 
severity were measured, with coefficients of determination for linear regression being R2 = 0.40 
for corneal thickness and R2 = 0.28 for K-max. The graph in Fig. 4D shows the distributions of 
Brillouin frequency shift values in cone regions of KC patients in comparison to Brillouin values 
measured in central regions of normal patients (within a 1-mm radius from the pupil center). 
While the reduction of Brillouin values is evident for advanced KC, no statistically significant 
difference was observed between stage-I-II KC and normal corneas. The mean Brillouin values 
of the stage-I and -II groups are lower than the healthy group by 3 and 7 MHz, respectively. 
Nonetheless, the observed null correlation results from large interpersonal variability within each 
group. Notably, the subject-to-subject variation in stage I and II patients is greater than the 
intrinsic interpersonal difference among healthy subjects. 
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Analysis of regional biomechanical variation in keratoconus corneas 
The observation of large interpersonal variability in both normal and KC corneas prompted us to 
seek metrics that are less subject to individual variations. We hypothesized that most of the 
variability stems from natural personal differences in the composition, collagen organization, 
and/or hydration level of corneal tissues. We further reasoned that these factors would likely 
affect Brillouin values uniformly across the entire cornea and therefore can be canceled out in 
differential metrics, such as regional difference within the cornea. From Brillouin maps, we 
found that, whereas normal corneas exhibit relatively uniform Brillouin values across their 
about-4-mm-wide scanned areas (Fig. 5A), the Brillouin shifts in KC corneas have a clear 
tendency to increase linearly with the distance from the cone in all stages, including stages I and 
II (Figs. 5B and 5C). The slope of regional variation increased with the severity of KC (Fig. 
S10). We compared the mean Brillouin frequency shift in the cone region versus outside-cone 
region—defined by all scanned points outside a 3-mm radius from the thinnest point—for each 
cornea. For healthy subjects, central and peripheral Brillouin values are not different (Fig. 5D, 
n=16, 39 ± 10 y/o, 25% female). By contrast, highly significant differences (p < 0.001) were 
found between cone and outside-cone regions for all stages of KC (Figs. 5E and 5F). Fig. 5G 
shows regional variations or the differences of outside- and inside-cone values for all groups. All 
KC groups exhibit higher regional differences than the normal group. However, the statistical 
significance is moderate (p < 0.01) except for stage IV, with considerable overlaps of Brillouin 
values with the normal group. 
 
Analysis of bilateral symmetry in KC corneas 
KC is known to be bilateral, but often asymmetric. The high degree of left-to-right symmetry in 
central Brillouin values in healthy subjects motivated us to analyze bilateral symmetry for KC 
corneas. Representative Brillouin maps from a patient with stage-I KC in both corneas are shown 
in Fig. 6A. The thickness and posterior elevation maps share symmetric, but not identical, 
features. Asymmetry in the Brillouin maps is apparent although subtle. To quantify the 
asymmetry, we calculated the difference in Brillouin frequency shifts between left (OS) and right 
(OD) eyes in two corresponding locations: near the pupil center and in the cone. The asymmetry 
in Brillouin values in the central regions of KC corneas was moderately higher (p < 0.01, n=4, 38 
± 5 y/o, 50% female) than in normal corneas (Fig. 6B). Remarkably, the Brillouin asymmetry 
between the left and right cone regions, which are identified using the thickness maps, is 
significantly larger than for the normal group (Fig. 6B). The mean bilateral difference in the 
stage-I cones was 24 MHz, well separated from the normal population that is predominantly 
below 12 MHz. Despite the relatively small sample size, the data are compelling and reveal that 
bilateral symmetry may be a promising metric for diagnosis of early-stage KC. The narrow 
distribution of the data suggests that the compounding factors that are responsible for the subject-
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to-subject variability in Brillouin values are equally present in both eyes and, therefore, cancelled 
out in this differential metric. 
 
Brillouin measurements of KC patients in vivo treated with collagen crosslinking 
CXL has previously been shown to increase Brillouin shifts in ex vivo porcine corneas, but it has 
remained unknown whether Brillouin shifts are altered following CXL in vivo in humans. To 
address this question, we conducted a cross-sectional study with KC patients who have been 
selected for and treated with CXL using a standard protocol at IROC in the past 1 to 4 years 
(n=16, 35 ± 11 y/o, 19% female). As a comparison group, we also recruited CXL-candidates 
who were eligible for CXL at IROC under consistent selection criteria —progressive, early-stage 
KC—and scheduled to undergo customized CXL54 at IROC (n=8, 26 ± 11 y/o, 50% female). The 
pre-CXL group had significantly lower (p < 0.001) Brillouin values (mean: 5.697 ± 0.029 GHz) 
compared to the central Brillouin shifts in the normal control group (5.722 ± 0.017 GHz, Fig. 7). 
A mild statistical difference (p < 0.05) was found between the pre-CXL (5.697 ± 0.029 GHz) and 
post-CXL (5.725 ± 0.030 GHz) groups in terms of Brillouin frequency shifts in cone regions 
(Fig. 7). Notably, no statistical difference was observed between the post-CXL and normal 
groups. Taken together, the results are consistent with the prevailing hypothesis that CXL in vivo 
does enhance the mechanical stiffness of weakened KC corneas. They further suggest that the 
degree of crosslinking induced by the current protocol is such that the corneal stiffness is brought 
to the normal level of healthy corneas. The SD in the post-CXL group was ± 30 MHz, slightly 
greater than ± 25 MHz and ± 17 MHz for the pre-CXL and normal groups, respectively. This 
broader distribution may be due to possible variability in the response to CXL procedures. 
 
DISCUSSION 
The magnitude of the optical frequency shift that we measure is proportional to the velocity of 
longitudinal acoustic waves in the tissue. The acoustic velocity is in turn related to the square 
root of longitudinal modulus of elasticity55. For viscoelastic materials such as tissues, 
longitudinal modulus is nearly equal to bulk modulus, or the material’s resistance to volume 
change. Because biological tissues are ~70% water by volume, they are nearly incompressible 
and exhibit high longitudinal modulus, in the range of 2.5 to 3.5 GPa for most tissues56, 
producing Brillouin frequencies of 5.69 to 5.77 GHz in corneas51 and up to 6.1 GHz in 
crystalline lenses57 (at an optical wavelength of 780 nm). The bulk modulus of aqueous humor, 
which is nearly the same as that of water, is 2.2 GPa, for which we measured a Brillouin shift of 
5.25 GHz (Fig. 1G). The higher longitudinal-modulus of corneal tissue compared to water 
derives from the contribution of the other constituent matter such as ions and proteins, that make 
the tissue less compressible. Brillouin spectroscopy has been shown to be sensitive to small 
differences in molecular composition, concentration (or water content)56, and photochemical 
crosslinking58,59. Brillouin measurement may be less sensitive to processes such as pure 
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polymeric rearrangement or changes that are predominantly entropic, but relatively more 
sensitive to processes involving changes in molecular concentration and composition. 
In contrast to bulk modulus, shear or Young’s modulus characterizes a material’s response to 
stress under free boundary conditions. Since soft matter is deformed relatively easily at constant 
volume, its shear modulus is orders-of-magnitude smaller than its bulk modulus. The shear 
modulus measured by mechanical methods at low deformation frequencies (< 100 Hz) is 
typically ~250 kPa for normal corneal tissue. Although longitudinal and shear moduli are in 
principle two independent quantities and can have vastly different magnitudes, empirical data 
obtained with polymers, hydrogels, and various tissues including corneas have shown reasonably 
high, quantitative correlation between Brillouin frequency shift and quasi-static shear 
modulus50,51,60. This measurement result suggests that in practice for corneal tissues, natural or 
pathologic processes that cause shear modulus to increase (or decrease) are likely to cause 
Brillouin shifts to increase (or decrease). 
Figure 8 illustrates a physical model of the cornea and how KC and CXL may influence 
different moduli of elasticity. The mechanical properties of corneal stroma are determined 
predominantly by the density and arrangement of collagen fibrils, which account for about 70% 
of the total corneal dry weight and are interconnected by proteoglycan and glycosaminoglycan 
(GAG) chains3,4,61. We expect that longitudinal modulus will decrease as the tissue degenerates 
in KC and that CXL can increase longitudinal modulus through accompanying molecular 
compaction (not directly by entropic contribution of crosslinks). Considering the typical 
relationship of density and refractive index (Methods), Brillouin frequency shift should change in 
the same direction as longitudinal modulus. 
The Brillouin data from normal adult corneas in vivo showed a modest age-dependence with a 
slope of ~3 MHz/decade. Unexpectedly, we observed relatively large subject-to-subject 
differences (± 24 MHz SD) even among age-matched subjects (Fig. 2A). Given the interpersonal 
variability, the rather small age dependence is surprising, as corneal surgeons often experience 
less soft and pliable corneas in old patients compared to young. Numerous ex vivo mechanical 
measurements have reported increasing trends of Shear and Young’s moduli with age62–64. About 
12% increase of Young’s modulus per decade has been estimated64. Employing an often-used 
empirical log-log conversion factor of 60:1, the slope of 12% per decade in Young’s modulus 
corresponds to, approximately, 0.2% per decade in longitudinal modulus, or 12 MHz/decade in 
Brillouin frequency (Supplementary Information). Previously, electron microscopy has revealed 
thickening of collagen fibrils65 and decrease of their inter-fibrillar spacing66 with age. Such 
changes in microstructure67, as well as age-related increase of glycation-mediated collagen 
crosslinking68, are thought to elevate corneal stiffness over age67. The apparent discrepancy 
between our measurement and previous ex vivo measurements (as well as surgeons’ perception 
by in vivo palpation) has yet to be resolved. It is interesting to note that in vivo measurements 
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using ORA found no increase or even small decline of corneal hysteresis and corneal resistance 
factor with age33,69–71. 
As an aside, ultrasound pachymetry—a current gold standard for corneal thickness 
measurement—assumes constant acoustic speed for all subjects and then calculates thickness 
from the time delay of ultrasound pulses reflected from two corneal surfaces72. The accuracy of 
commercial ultrasound pachymeters is known to be < ± 1%. Based on our Brillouin data, we 
expect hypersonic-wave-based thickness measurement to have an error of ~ ± 0.4% (± 24 MHz / 
5.72 GHz) associated with the interpersonal and age-dependent variability. 
We supposed that the interpersonal variability stems from natural differences in individual’s 
normal physiological conditions. For example, Brillouin shift is sensitive to the water content in 
hydrogels and, therefore, hydration level of corneal tissues73. The hydration level is known to 
differ individually and fluctuate throughout the day74. This hydration variation is likely to 
contribute to the measured interpersonal variability. Brillouin shift of tissue can also be sensitive 
to body temperature, as expected from a temperature dependence of 7.4 MHz/°C for water (Fig. 
S6). In the future, it would be possible to record body temperature and apply a correction factor 
to measured Brillouin values. Since these physiological factors affect globally the entire cornea, 
we had expected much smaller interpersonal variability for differential metrics. Indeed, we 
measured substantially smaller “intra-personal” differences between left and right eyes (Fig. 2B) 
and between the central and peripheral regions of each cornea (Fig. 5D). 
Variability in corneal biomechanics across individuals can introduce significant errors in 
applanation-tonometry IOP readings75. Hence, individual differences in Brillouin value may be 
used to apply a “biomechanics correction” to improve the accuracy of IOP measurements. 
Individual differences in Brillouin value may also provide useful input for refractive treatments: 
it is known that corneal hydration affects the excimer laser ablation rate in LASIK surgeries76,77, 
and personal biomechanical differences are thought to explain the variability in refractive 
outcomes following cataract and astigmatic correction keratotomy (AK) surgeries78. It may be 
possible to individually tailor ablation parameters or AK nomograms based on Brillouin 
measurements made prior to treatment. 
In the present study of KC patients, we confirmed our previous finding that the cones in 
advanced KC corneas show up clearly in Brillouin maps as the regions with significantly reduced 
Brillouin shifts (Fig. 3B)51. However, the correspondence between Brillouin maps and 
pachymetry and topography is less clear in early-stage KC corneas, and Brillouin shifts correlate 
weakly with morphological parameters such as thickness and curvature (Figs. 4B and C). We 
found no statistical difference between stage-I-II KC patients and healthy subjects (Fig. 4D). The 
Brillouin values within stage-I and II groups each exhibited larger inter-subject variation than the 
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normal group. The large variations might originate from the physiological factors discussed 
above and, possibly, additional factors associated with KC pathogenesis. 
The distinction between early-stage KC and normal groups was more pronounced in the analysis 
of regional differences between cone and outside-cone regions. In most stage-I and -II subjects 
and all stage-III and IV subjects, the cone regions had lower Brillouin shifts than the peripheral 
regions. This supports the long-held hypothesis that the degeneration of corneal tissues occurs 
focally at the cones17. Given moderate statistical significance (p < 0.01) between stage-I and 
normal values, the regional-difference parameter has potential to be a useful metric to 
characterize early-stage KC. However, the two-point comparison alone is unlikely to be 
diagnostic of KC, considering the overlap of data between different groups (Fig. 5G). With more 
accurate, comprehensive mapping of the cornea in future, more sophisticated metrics based on 
specific spatial patterns in Brillouin maps may be developed. 
The most promising metric we have found is the difference in Brillouin shifts between left and 
right eyes. The bilateral asymmetry measured in stage-I KC patients is clearly separated from 
that of normal corneas, and reflects the clinical experience that in many keratoconus patients one 
eye shows a more advanced stage of disease relative to the other79. It warrants more investigation 
of this metric in a larger scale study, which may include patients with only one eye in stage-I KC 
and a subclinical or KC suspect contralateral eye. The bilateral asymmetry indices of healthy 
subjects form a normal distribution with width limited by the system’s sensitivity. With 
enhanced Brillouin signals through longer data acquisition time, the distribution in the healthy 
population may turn out to be narrower. The bilateral asymmetry index may prove useful for 
identifying patients at an earlier stage or those at risk of developing KC. If so, this index could be 
used to develop new diagnostic criteria in combination with, or even beyond the current 
morphology-based gold standard. It is worthwhile to note that it is the bilateral asymmetry 
measured at the thinnest point that showed the sharp distinction. The asymmetry index measured 
at the pupil center showed only moderate statistical difference from the normal population (Fig. 
6B). This consistently supports the hypothesis of focal weakening in the development of KC17. 
Besides corneas, other ocular tissues such as the crystalline lens and sclera are thought to present 
a high degree of symmetry in their healthy states. In fact, in our previous study of crystalline 
lenses in vivo, we have measured large interpersonal variability, as much as ± 60 MHz in age-
matched groups, as opposed to small differences between left and right lenses within the 
measurement uncertainty of ± 10 MHz57. Brillouin-based bilateral asymmetry has potential to be 
a general, useful technique for the detection of subtle pathological anomalies and drug-induced 
changes in the biomechanical properties of the lens and sclera. 
We have also presented the first in vivo Brillouin data from patients after clinical CXL treatment. 
The mean Brillouin shift of the post-CXL group was 30 MHz higher than the pre-CXL group, 
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providing evidence for the positive effect of CXL on the stiffening of corneal stroma. However, 
the statistical significance of this finding was modest (p < 0.05), in part due to the large 
interpersonal variation in, particularly, the post-CXL group. Previously we have observed a 
depth-dependent, dramatic increase of Brillouin shifts, as much as a few hundred MHz, in 
porcine and bovine corneas immediately after ex vivo CXL58. Judging from the in vivo data, the 
dramatic increases measured ex vivo were likely exaggerated, presumably by CXL-induced 
tissue compaction and hydration changes—possible artifacts in ex vivo experiments. Our data 
clearly showed milder post-CXL increase in vivo, presumably because of the regulation of 
hydration level and remodeling of collagen fibrillar structure. Numerous studies have been 
conducted using ORA and Corvis ST instruments to measure the biomechanical effects of CXL 
both ex vivo and in vivo, so far producing informative but mostly inconsistent results. For 
example, several in vivo studies found no significant change in the magnitude of corneal 
deformation with air puffs following CXL80–82, whereas in ex vivo samples CXL clearly resulted 
in reduced corneal deformation83,84, suggestive of stiffening. Our data represents the first in vivo 
indication of post-CXL corneal stiffening. 
The observation of large interpersonal variation following CXL treatment motivates future 
longitudinal studies in which KC patients are scanned pre- and post-CXL and the differential 
changes in Brillouin shifts are monitored over time. The time-lapse data will have much lower, 
self-canceled interpersonal variation and may provide quantitative, mechanistic insights into the 
effects and variability of CXL procedures. 
The current Brillouin systems require a data acquisition time of > 0.2 s per depth point and ~12 s 
for a single axial scan. In clinical practice, this speed would be acceptable for acquiring data at 
only a few locations, such as the thinnest point and a peripheral point, which would be sufficient 
for measuring the regional difference and bilateral asymmetry. However, improvement of speed 
will permit more comprehensive mapping of the entire cornea (~9 mm diameter) in a short time 
acceptable in clinical settings. The total number of Brillouin scattered photons that were 
collected and analyzed at the spectrometer was about 3 ´ 10-13 of the number of laser photons 
incident on the corneal surface. The theoretical maximum collection efficiency of Brillouin light 
scattering in an on-axis confocal configuration is estimated to be !"#$% ('#())#+ 𝑘-𝑇, where 𝑘-𝑇 = 
4.23 ´ 10-21 J at the cornea temperature, n is refractive index, K is bulk modulus, and l is optical 
wavelength (Supplementary Information). For corneal tissues, the efficiency is ~ 5 ´ 10-11. There 
is room to increase the Brillouin signal by as much as 10-fold by reducing optical loss in the 
detection path. 
In conclusion, these clinical results have demonstrated the diagnostic potential of Brillouin light 
scattering spectroscopy for corneal examinations, particularly for detection and treatment 
monitoring of KC patients. The two most promising metrics for KC-discrimination are based on 
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bilateral asymmetry and focal weakening in early-stage KC patients, a finding made possible by 
harnessing the intrinsic ability of Brillouin technology to measure local biomechanical properties 
of tissues with high spatial resolution and sensitivity. Our results suggest that spatially-resolving 
Brillouin spectroscopy may prove useful not only for the diagnosis of KC but also for improving 
CXL treatment54, and potentially in many other applications, including screening subjects at risk 
of ectasia prior to refractive keratectomy surgeries15,16,85 and optimizing corneal incision 
parameters in cataract and astigmatic correction keratotomy surgeries by taking individual 
biomechanics into account78. Brillouin measurements may also be used to improve the accuracy 
of basic examinations such as intraocular pressure measurement75. 
 
MATERIALS AND METHODS 
Study design 
The objective of this study was to assess the feasibility of using Brillouin spectroscopy for 
clinical characterization of human corneal biomechanics. Specifically, to evaluate the potential 
of Brillouin spectroscopy for diagnosis and treatment of keratoconus. For this purpose, we 
examined the interpersonal variability, age-dependence, regional heterogeneity, and bilateral 
asymmetry in Brillouin values among normal corneas, keratoconus corneas of different severity, 
and corneas with history of collagen crosslinking treatment. 
The general inclusion criteria were subjects with clear enough cornea or clear enough media to 
permit imaging, and who fulfill all specific inclusion/exclusion criteria of each study group. 
Excluded from this study were monocular volunteers. The normal cornea group included healthy 
subjects with normal appearing corneas respecting all the general inclusion/exclusion criteria, 
with less than ± 3 diopters refractive error, normal corneal thickness (495 to 600 µm), normal 
corneal topography (no asymmetric or irregular astigmatism, no skewed axis), no corneal 
pathology, and no history of eye diseases, except presbyopia and/or cataract. The keratoconus 
group included subjects with irregular corneas determined by distorted keratometry mires or 
irregularities in Scheimpflug photography, and slit-lamp biomicroscopic signs such as Vogt’s 
striae or Fleischer’s ring or corneal scarring consistent with keratoconus. The CXL-treated group 
included patients having undergone CXL surgery within the past 4 years and excluded corneas 
with scarring or having undergone additional ocular surgeries, such as laser vision correction 
surgeries. 
Sample sizes for each group were chosen in advance based on a power analysis. We used 
preliminary data to estimate the sample size required to establish a correlation between corneal 
stiffness and progression of the disease, subject age, or treatment with CXL, with > 90% power. 
Studies were performed at two locations: at the Institute for Refractive and Ophthalmic Surgery 
(IROC) in Zürich, Switzerland, and at Massachusetts Eye and Ear Infirmary (MEEI) and 
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Massachusetts General Hospital (MGH) in Boston, USA, following approval from the 
Institutional Review Board (IRB) of Partners HealthCare, the Partners Human Research 
Committee (PHRC) and the Institutional Review Board of IROC, Zürich. Informed consent was 
obtained from every patient before imaging. The clinical trial “A Study to Test the Potential 
of Brillouin Microscopy for Biomechanical Properties Measurements in Human Cornea” is 
registered at www.clinicaltrials.gov (National Clinical Trial Identifier: NCT03220529). 
Brillouin data acquisition 
During Brillouin measurement, the subject sits with their chin and forehead resting in the human 
interface headrest, directing their gaze towards a fixation target. For healthy subjects with normal 
corneas, 5 axial scans are taken within a Æ2 mm zone in the central cornea. To create a Brillouin 
map of the cornea, 20 – 40 axial scans are taken at different locations laterally across the cornea, 
usually within the central Æ6 mm zone. Light power was calibrated to be 5 mW on the cornea 
surface. Each axial scan comprises 40 points separated by a step size of 30 µm, spanning air to 
cornea to aqueous humor. The EMCCD exposure time for each step is typically 300 ms, 
resulting in a total axial scan time of about 12 s. Following each axial scan, temperature-
corrected calibration spectra are taken using known reference materials (polystyrene and water) 
to determine the dispersion rate (in GHz/pixel) of the spectrum pattern acquired from the cornea, 
and thus the corresponding Brillouin frequency shift (Fig. S3). From the calibrated axial scan 
data, points acquired within the corneal stroma are extracted and averaged to yield a single value 
for each lateral scan location (Fig. 1G). Linear interpolation between these lateral measurement 
points is then used to create the final 2D Brillouin map (Fig. 1H). Data processing was conducted 
using MATLAB (Mathworks, Inc.). 
Corneal topographies 
The corneal topographies were generated using a commercial topographer (Vario, Wavelight, 
Erlangen, Germany) and a commercial Scheimpflug camera (Pentacam HR 70700, OCULUS, 
Wetzlar, Germany). Patients were asked not to use contact lenses in the two weeks prior to each 
examination. 
Corneal collagen crosslinking 
Patients receiving CXL suffered from a documented progressive, primary keratoconus. Excluded 
from this study were eyes with previous ocular surgery, penetrating trauma, glaucoma, aphakia, 
endothelial cell count less than 2300 cells/mm2, corneas with no distinctive posterior float area, 
pellucid marginal degeneration, corneal scars that may interfere with Scheimpflug photography, 
history of recurrent erosions, neurodermatitis and connective tissue diseases, or pregnancy and 
breast feeding. Eyes treated before October 2016 received standard CXL (Dresden protocol, 5.4 
J/cm² using 9 mW/cm²) including a 9.0 mm circular epithelium debridement and application of 
0.1% riboflavin in 16% dextran T500 for 30 minutes. After October 2016, customized CXL of 
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the cornea was performed using an irradiance of 15 mW/cm² and a variable radiant exposure 
(Mosaic, Avedro Inc., Waltham, MA)54. 
Data analysis 
To process a single axial scan, we first determine the rate of spectral dispersion using the 
included calibration spectrum (see Fig. S3). With this information, we can then determine the 
Brillouin frequency shift at each of the (typically) 40 scan points spanning air to cornea to 
aqueous humor. We then segment this Brillouin shift versus axial depth data, based on Brillouin 
value and other characteristic signal features, in order to identify and extract only points within 
the corneal stroma. Finally, we average the Brillouin shift measured across all stroma points to 
obtain a single Brillouin value for the axial scan. 
To create a Brillouin map of the cornea, we use standard linear interpolation to connect Brillouin 
values from 20-40 axial scans at different lateral locations. To analyze the spatial variation in 
Brillouin values across the cornea, we define various regions of interest (see Fig. S9 for a 
graphical illustration of these zones). The central region is defined as the zone within a 1-mm 
radius around the pupil center; the peripheral region is the area with a distance > 3 mm from the 
pupil center. In keratoconic corneas, the ‘cone region’ is defined as the area within a 1 mm 
radius of the thinnest point (the ‘cone center’) identified using corneal topography, and the 
‘outside-cone region’ refers to the area > 3 mm from the cone center. 
Statistical analysis 
Custom MATLAB software was used for data processing. Statistical analysis was carried out 
using the Statistics toolbox in MATLAB. To examine the significance of differences observed in 
the mean Brillouin values of different groups of subjects (such as comparing normal versus KC 
stage I) we used unpaired, two-tailed t-tests. To evaluate the significance of differences observed 
within a single cornea (such as comparing one region to another) we used paired, two-tailed t-
tests. Data were considered significant if p-values were less than 0.05 (95% confidence 
intervals). 
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Fig. 1. The Brillouin ocular analyzer system. (A) The tabletop Brillouin imaging system in the 
laboratory at Massachusetts General Hospital in Boston. (B) Brillouin measurement of a 
volunteer by an operator, using the portable Brillouin ocular scanner in the clinical setting at 
IROC in Zürich, Switzerland. (C) Schematic of the Brillouin imaging system, composed of three 
parts: a light source, a human scanning interface built on a modified slit-lamp platform, and a 
high-resolution, two-stage VIPA spectrometer consisting of two crossed-axis VIPA etalons. OI: 
optical isolator; PD: photodiode; BS: beam sampler; PMF: polarization maintaining single-mode 
fiber; SMF: single mode fiber; 𝜆/2: half waveplate; 𝜆/4: quarter-waveplate; M: mirror; Obj. L: 
objective lens; PBS: polarizing beam-splitter; S1/S2: optical shutters; Ref: reference materials; 
C1/C2: cylindrical lens; A1/A2: achromatic lens; S1/S2: shutters; V1/V2: VIPAs. (D) Probe 
beam geometry. (E) Representative Brillouin signals from the cornea recorded in vivo using the 
EMCCD camera in the spectrometer. (F) An eye-tracking camera view showing locations of 
axial scans (red dots). (G) A representative axial (depth) scan profile of measured frequency 
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shifts across the cornea and anterior chamber of a healthy volunteer. (H) A typical Brillouin 
elasticity map of a normal cornea. 
 
 
 
 
Fig. 2. In vivo Brillouin measurements of normal corneas. (A) Brillouin frequency shifts 
measured at corneal centers in healthy subjects of various ages (n=47, 39 ± 13 y/o, 51% female). 
Broken line depicts a linear regression fit with a slope of 0.3 ´ age MHz/year, with Pearson’s p = 
0.06, 𝑟! = 0.08. (B) Comparison of Brillouin shifts between the left (OS) and right (OD) eyes of 
each subject (n=37). No statistically significant difference is found. (C) Distribution of OD-OS 
difference (mean: 0.0018 ± 0.007 GHz), from 37 subjects whose eyes were both scanned (38 ± 
14 y/o, 60% female). 
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Fig. 3. Representative Brillouin images of corneas in vivo. (A) normal corneas (subjects i to iii), 
(B) corneas diagnosed with keratoconus in Stage I (iv-vi), and (C) corneas with severe 
keratoconus in Stage III or IV (vii-ix). The circles (black) indicate an area of 9 mm in diameter 
centered at the pupil center. Rows 2-4 are topographical images of the corneas, showing corneal 
thickness, sagittal curvature, and posterior surface elevation. (Note the difference in color maps 
and ranges due to difference in clinical Scheimpflug imaging systems.)  
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Fig. 4. Correlation between Brillouin frequency values and KC severity. (A) Locations of the 
thinnest points identified by pachymetry in patients diagnosed with KC stage I or II (n=34, 36 ± 
11 y/o; 47% female) or KC stage III or IV (n=12, 46 ± 14 y/o; 75% female). (B) Correlation of 
Brillouin shift with corneal thickness. (C) Correlation of Brillouin shift with sagittal curvature. 
Dashed lines: linear fits. (D) Comparison of Brillouin frequency values of normal subjects and 
KC patients at different stages: I (n = 25, 36 ± 11 y/o, 46% female), II (n = 9, 45 ± 13 y/o, 44% 
female), III (n = 4, 47 ± 12 y/o, 40% female) and IV (n = 8, 45 ± 15 y/o, 25% female). n.s.: non-
significant, ***: p < 0.001, by unpaired t-test. 
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Fig. 5. Spatial variation of Brillouin frequency value across corneas. (A-C) Lateral variation of 
Brillouin shifts in: (A) normal subjects, (B) stage-I KC patients, (C) stage-II KC patients. Circles 
and shaded regions represent average and SD of 4 to 16 maps. (D-F) Pairwise comparison of 
Brillouin values in corneal centers or cones to Brillouin values in peripheral regions, for (D) 
normal subjects (n=16, 39 ± 10 y/o, 25% female), (E) Stage I-II KC, (F) Stage III-IV KC 
patients. **: p < 0.01, ***: p < 0.001, by paired t-test. (G) Difference in Brillouin shift measured 
in the outside-cone (peripheral) versus cone (central) regions for KC and normal (N) groups. n.s.: 
non-significant, **: p < 0.01, ***: p < 0.001, by unpaired t-test. 
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Fig. 6. Bilateral asymmetry in early-stage KC. (A) Brillouin, corneal thickness and posterior 
elevation maps of the right and left eyes of a stage-I KC patient. Broken red circles denote 1-
mm-radius cone regions centered at the thinnest points. (B) Absolute difference in Brillouin 
frequency values between left and right eyes, measured at the corneal centers for normal (green) 
subjects and stage-I KC patients (beige) and at the thinnest points for the KC patients (n=4, 38 ± 
5 y/o, 50% female). **: p < 0.01, ***: p < 0.001, by unpaired t-test. 
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Fig. 7. Brillouin analysis of CXL. Brillouin frequencies measured in three groups: normal, CXL 
candidates prior to CXL, and post-CXL patients within 1 to 4 years after treatment. *: p < 0.05, 
***: p < 0.001, by unpaired t-test. 
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Fig. 8. Models of normal, diseased, and CXL-treated corneal tissue and corresponding changes 
in bulk (K), shear (G), and longitudinal (M) moduli of elasticity. The corneal stroma features 
hexagonal arrangements of collagen fibrils and interconnecting proteoglycan glycosaminoglycan 
(GAG) chains (left panel). Transmission electron microscopy showed that collagen fibrils have a 
uniform diameter of 25-30 nm in normal corneas61,86, but exhibit reduced diameter in KC 
corneas87. The degradation of collagen fibers and loss of GAG and proteoglycan loosens the 
microstructural arrangement and leads to a decrease of shear and bulk moduli, and, therefore, 
longitudinal modulus (middle panel). CXL induces compaction of the structure and promotes 
regeneration of the constituents88, consequently increasing shear, bulk, and longitudinal moduli 
of elasticity (right panel). The changes in longitudinal modulus, which may be spatially 
heterogeneous, can be probed noninvasively by Brillouin light scattering microscopy. 
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Relation of Brillouin frequency shift and longitudinal elastic modulus  
Spontaneous Brillouin scattering is the scattering of light from acoustic phonons (i.e. propagating 
density waves originating from intrinsic thermal fluctuations) [1,2]. Light scatters from acoustic 
waves that are phase-matched, resulting in a negative (Stokes) and positive (Anti-Stokes) 
Doppler frequency shift of the light by the frequency of the mechanical waves. It is the 
(absolute) magnitude of Brillouin frequency shift that we measure with our optical spectrometer. 
Although both shear and longitudinal waves are present in the tissue, our Brillouin instrument is 
configured to measure 180º back-scattering from longitudinal 
waves only (Fig. 1). In this back-scattering configuration, the 
Brillouin frequency shift Ω is related to the acoustic speed V, 
via V = 	Ω 5!6 , where λ is the wavelength of the light, and n is 
the refractive index of the tissue. The acoustic speed is itself a 
function of the longitudinal elastic modulus M through the 
relation V = M/ρ , where ρ is the mass density of the 
tissue.  From this equation, we get ∆== = ∆>!> + ∆66 − ∆A!A. Based 
on published data [3,4], we estimate A6# ≈ 0.565 to 0.5635 
g/mL, varying <0.3% within normal corneas. Therefore, the 
last two terms are nearly canceled out. In general, the acoustic speed has directional dependence 
and M is a tensor. If we approximate the corneal tissues as a mechanically isotropic material, the 
relationship between different mechanical moduli is as follows: G = K E()(!F)()GF) ;M = K + IJE , 
where G is shear modulus, K is bulk modulus, and n is Poisson’s ratio. K is an inverse of volume 
compressibility. In tissues, M is approximately equal to K. The typical value of longitudinal 
modulus is several GPa whereas that of shear modulus of tissues is in a 10-100 kPa range [5].  
  Empirically, we have previously observed a relatively high correlation between 
longitudinal modulus (M) and quasi-static shear modulus (G) in ex vivo porcine corneas (Fig. S2) 
when fit to a log-log linear curve: log M = 𝑐 log G + 𝑑, with fitting parameters c = 0.033 and 
d = 9.31. For ex vivo samples, the effect of swelling may contribute to the apparent correlation 
between longitudinal and shear moduli. That is, tissues with low shear modulus tend to swell 
more, and the increased swelling reduces longitudinal modulus. We do not yet know to what 
extent the observed empirical relation would hold in the physiological condition in vivo, in which 
tissue hydration is regulated. Regardless, the Brillouin frequency shift itself is a convenient 
metric directly measurable with Brillouin light scattering spectroscopy. In this paper, we report 
our measurements as Brillouin frequency shifts in GHz. 
 
Fig. S1: Brillouin light 
scattering in the cornea. 
 29 
 
Fig. S2: Empirical quantitative relationship between Brillouin modulus (frequency shift) and 
shear modulus (G). (a) Comparison data for thin flaps of porcine corneal tissue ex vivo (each data 
point corresponds to one thin flap). Cornea tissue was cut with a biopsy punch to retrieve thin 
flaps from the anterior, central, and posterior regions. Shear modulus of the thin flaps was 
measured using a stress-controlled rheometer (ARG2, TA Instruments) at 0.5 Hz with 0.1% 
strain amplitude. High correlation (R = 0.9) was obtained with c = 0.033 and d = 9.31. (b) Data 
from (a) grouped by corneal region and plotted versus Brillouin frequency shift measured at a 
wavelength of 532 nm.	
 
The magnitude of Brillouin scattering 
The scattering cross section for Brillouin scattering in an isotropic liquid is given by [6]  
𝜎 = 𝜋!𝑉2𝜆I 𝛾!𝐾 𝑘-𝑇(1 +	cos!𝜃) 
where 𝜆 is the optical wavelength, 𝛾 is the adiabatic electrostriction constant, K is the adiabatic 
bulk modulus (at the Brillouin shift frequency), 𝑘- is Boltzmann constant, 𝑇 is the temperature, 𝑉 is the volume of the interaction region, and 𝜃 is the scattering angle. The adiabatic 
electrostriction constant is a dimensionless measure of the change of the refractive index upon 
density variation, i.e. 𝛾 = 𝜌([\[]), where 𝜀 is dielectric constant and 𝜌 density. To a good 
approximation, 𝛾 is equal to 𝜀 − 1 = 𝑛! − 1. The normalized magnitude of scattering is 
therefore given by 
𝑆 = 𝜎𝐴 = 𝜋!𝐿2𝜆I 𝛾!𝐾 𝑘-𝑇(1 +	cos!𝜃) 
where A and L are the area and length of the interaction region, respectively. We consider a 
Gaussian probe beam focused to a spot with numerical aperture, NA, in free space. Then, 𝐿 ≈!$"(cd)#. In an on-axis, backward confocal geometry (𝜃 close to 180°), only the scattered light 
within the solid angle given by the numerical aperture is collected. Integrating the angle-
dependent term, (1 +	cos!𝜃), over this range yields ≈ 2𝜋(𝑁𝐴)!. Therefore, the total amount of 
light collected as a fraction of the laser photons incident on the cornea is:  
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𝑆fghhifjik = 2𝜋!𝜆E 𝛾!𝐾 𝑘-𝑇 
For cornea tissues, we use 𝑛 = 1.376, K = 2.6 ´ 109 J/m3, 𝑘-𝑇 = 4.23 ´ 10-21 J (cornea 
temperature ~33°C), and 𝜆 = 0.78 ´ 10-6 m, and obtain 𝑆fghhifjik = 5.4 ´ 10-11. The scattering 
efficiency of measurement is independent of NA. It is interesting to find that the collection 
efficiency is proportional to 𝜆(E, while the total amount of scattering is proportional to 𝜆(I as is 
well known for Rayleigh and Brillouin scattering. 
 
Brillouin microscopes  
 
Light source  
The light source is a single-frequency, external cavity diode laser (ECDL) with a center 
wavelength of 780 nm (Vantage TLB-7113, New Focus). Amplified spontaneous emission 
(ASE) present in the ECDL output is suppressed by approximately 20 dB by passing the laser 
light through a solid silica, Fabry-Perot etalon (FSR = 15.14 GHz, finesse = ~32, 
LightMachinery). A small amount of laser light (~4%) is picked off following the etalon and 
measured with a photodetector so that the ECDL center frequency can be actively locked to a 
transmission peak of the etalon. The resulting fluctuations in laser intensity after locking are < 
5%. Locking the laser to the etalon also reduces wavelength drift of the ECDL output, such that 
the absolute stability is ± 20 MHz over 5 minutes, limited by temperature-induced/mechanical 
drift of the etalon itself  [7]. An optical isolator (IO-5-780-VLP, Thorlabs) is placed directly 
following the laser output port to prevent back-reflections from entering the laser.  
 
Human interface  
Laser light is carried to the human interface via polarization-maintaining single-mode optical 
fiber (PM780-HP, Thorlabs), where it is collimated and then split into sample and reference arms 
using a half-wave plate and polarizing beam splitter (CM1-PBS252, Thorlabs). In the sample 
arm, laser light is focused onto the cornea using a microscope objective (20x, effective NA = 0.1, 
Mitutoyo). In the reference arm, laser light is focused onto two known reference materials: 
polystyrene and water at room temperature, through an achromatic doublet lens (f = 30mm, 
Thorlabs). The temperature of the reference materials is monitored and saved in real-time so that 
temperature calibration can be applied to the reference spectrum. In both sample and reference 
arms, a quarter-wave plate is inserted so that back-scattered light is transmitted through the 
output port of the polarizing beam splitter, where it can then be coupled into a single-mode 
optical fiber (780HP, Thorlabs) for transmission to the spectrometer. The human interface is 
mounted to a stripped-down slit lamp headrest with joystick-based spatial manipulator allowing 
for manual adjustment of the lateral scanning location on the cornea. The objective lens is 
mounted on a motorized translation stage (T-LSM025A, Zaber Technologies), allowing for 
automated axial scanning through the corneal depth. At normal incidence, specular reflection 
significantly diminishes the signal-to-noise ratio of the Brillouin spectrum. Thus, it is necessary 
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to tilt the human interface by about 15° with respect to the head rest, and additionally have the 
subject fixate their gaze on a target making an angle of about 10° (in the opposite direction) with 
respect to the head rest, so that the incidence angle is > 10° over a central zone of ~Æ6 mm 
laterally across the cornea. 
For eye tracking, a light emitting diode (940 nm, ~2 mW on sample surface, M940L3, 
Thorlabs) is used. The near-infrared range is chosen because it reduces the sensitivity of 
intensity-based pupil-detection algorithm to eye color. The eye is imaged using a high-resolution, 
monochrome CMOS camera (Mako G-419B, Allied Vision). A long-pass filter is used to reject 
the laser line and background room lights. Frames are captured on the CMOS camera 
synchronously with the EMCCD (but at a higher frame rate) so that events such as blinking or 
eye movement can be identified. Because the relative positions of the objective lens and CMOS 
camera are fixed, the laser location on the CMOS camera is stationary. Hence, the lateral 
coordinates for each axial Brillouin scan be determined relative to the pupil center by detecting 
the pupil location in each CMOS camera image. 
 
Spectrometer  
The spectrometer design is based on two virtually imaged phase array (VIPA) etalons in a cross-
axis configuration, similar to that reported previously  [8,9]. The two VIPAs used are identical 
(R1 = 99.9%, R2 = 95%, tilt angle ≈ 1.5°, LightMachinery). A series of lenses (cylindrical 
lenses C1 and C2, plus spherical lenses A1 and A2) with focal length 200 mm are used to focus 
light onto the VIPAs, where angular dispersion occurs, and to relay light to two spatial filters (S1 
and S2), which block undesired spectral components (Rayleigh peaks). The gradient intensity 
filter (G) following the first VIPA (V1) enhances the spectral contrast by reshaping the intensity 
profile along the dispersion direction  [10]. The first VIPA (V1) is oriented vertically, while the 
second VIPA (V2) is oriented horizontally, resulting in a net frequency dispersion along the 
diagonal axis, which is imaged onto a diagonally-oriented, electron-multiplying charge-coupled 
detector (EMCCD, iXon 897, Andor Technologies) using a telescope (T). In the portable system, 
additional folding mirrors are used to make the spectrometer more compact. Typical Brillouin 
signal counts detected at the EMCCD are on the order of 900 photons/s, requiring exposure times 
of 100 – 400 ms. The rate of spectrum dispersion on the EMCCD is ~0.125 GHz/pixel.  
 
Table S1. Specifications of the Brillouin Systems  
Parameter Value 
Laser wavelength 780 ± 0.2 nm 
Laser power on the cornea 3 – 5 mW 
Data acquisition time per point 0.2 – 0.4 s 
Transverse resolution ~ 5 µm 
Axial resolution ~ 35 µm 
Spectral sensitivity ~ ± 8 MHz 
Measurement repeatability ~ ± 10 MHz 
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Spectrometer frequency calibration 
To calibrate the spectrometer, we used two materials with known Brillouin shifts, water and 
Polystyrene (PS). Frequency shifts of the two materials at room temperature were pre-
determined with calibrated spectrum dispersion, as Ωlmnop = 5.11 GHz and Ωqr = 9.62 GHz, 
respectively. Spectral dispersion rate is then determined by:  
            SD = 2 ∗ =tu(=vwxyzqtu{|	(	qtu{})G(q~{|(q~{}    
where Pqr( and Pqr(, Pl( and Pl( are paired peaks in the reference signal from PS and 
water, respectively (Fig. S3d). Precise free spectral range during a measurement is estimated as: 
FSR = 2 ∗ Ωqr − Pqr( 	−	Pqr( ∗ SD 
Sample frequency shift Ω is defined as the distance along the spectrum line from the Rayleigh 
peak (laser line, blocked by optical shutter and therefore not visible in this figure) to the fitted 
signal peak, and is given by (Fig. S3b): Ω = 0.5 ∗ [FSR − (P! − P))	] 
 
 
Fig. S3: Spectrometer frequency calibration. (a) EMCCD recording of a typical sample signal. 
(b) Plot of signal intensity across spectrum line from (a) and resulting fit to a Lorentzian 
function. Dots: pixel intensity values; dashed line: fitting results. (c) EMCCD recording of a 
typical signal from reference materials, water and Polystyrene (PS) by focusing light on the 
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water-PS interface. (d) Plot of signal intensity across spectrum line from (c) and the resulting fit 
to a Lorentzian function. Dots: pixel intensity values; dashed line: fitting results. 
 
Signal-to-noise ratio (SNR) and measurement sensitivity  
For a CCD detector, shot noise is ideally the primary contributor to signal-to-noise ratio (SNR), 
with negligible contribution from dark current and readout noise (operation in the so-called, shot-
noise-limited regime). However, in detectors using amplifying technologies, such as EMCCDs, 
the signal multiplying process increases the degree of variance in the signal around the mean 
value. Technically the detectors work in the shot-multiplicative-noise-limited regime in the best 
case. For simplicity, we still use the term ‘shot-noise-limited regime’.  Our spectrometer reading 
is background free and works in this regime. To verify this, we measured the SNR at different 
illumination energy levels on a piece of poly(methyl methacrylate) (PMMA) material, using 5 
mW input power and integration time increasing from 50 to 600 ms. For each illumination level, 
50 measurements were obtained continuously at a single location on the sample. SNR is defined 
as the ratio of mean signal intensity to standard deviation of signal intensity. A good square root 
dependence of SNR on the product of illumination power and integration time (total number of 
photons collected) was found, suggesting shot-noise limited operation (Fig. S4a). In this regime, 
the measurement accuracy is ultimately limited by the SNR. To find an optimal operating point, 
we plot measurement errors (standard deviation of measurements) versus 1/SNR. An EMCCD 
integration time of 0.2 s corresponds to standard deviation of <10 MHz at 5 mW. In Fig. S4c, we 
show the resulting distribution of estimated Brillouin frequency shifts using these settings (5 
mW, 0.2 s) when the measurement is repeated 400 times continuously. The standard deviation of 
these measurements is ± 7.8 MHz. This corresponds to a relative measurement uncertainty of ~ 
0.1 to 0.2%.  
 
  
Fig. S4: Signal to noise ratio and measurement sensitivity. (a) Plot of signal-to-noise ratio versus 
optical energy. Line: linear fit. (b) Plot of measurement error (based on standard deviation of 5 
consecutive measurements) versus inverse SNR. Line: linear fit (c) Histogram of estimated 
Brillouin values over 400 consecutive measurements. Standard deviation is ± 7.8 MHz. 
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Light delivery to and light collection from the sample is arranged in a confocal configuration. 
The foci for light delivery and light collection overlap, hence the spatial resolution is determined 
by the focal power of the objective lens. Lateral resolution is calculated to be approximately 𝑅hjih ≈ 5 µm. We experimentally determine axial resolution. An edge spread function ESF(z) 
was obtained via axial scanning though the plastic-water interface of a PMMA cuvette, with a 
step size of 20 µm. The axial resolution is estimated to be Rmm =  ESF z ≈ 35 µm, given by 
the FWHM of the fitted Gaussian profile to the ESF (Fig. S5b).  
 
  
Fig. S5. Axial resolution. (a) Axial scanning profile of a PMMA-water interface. (b) Fitted 
Gaussian function to the 1st order derivative of the interface edge spread function ESF, from 
which we estimate the axial resolution of the system to be around 35 µm. 
 
 
Temperature dependence of Brillouin measurements and calibration 
 
Brillouin frequency shift is temperature-dependent, so temperature fluctuation of the reference 
materials will cause error in our calibration, and hence our estimation of the Brillouin frequency 
shift of the sample. We studied the temperature dependence of the reference materials and 
applied a temperature correction in post-processing to alleviate its effect on measurements. We 
first measured Brillouin frequency shift in water versus temperature and compared with 
theoretical prediction (Fig. S6a), calculated using Ω = 2𝑛 $ sin	(𝛽), where 𝑛 is the refractive 
index of water, 𝑣ji is the speed of sound in water, 𝜆 is laser wavelength, which in this study 
was 780 𝑛𝑚, and 𝛽 = 180° is the scattering angle.  Refractive index and speed of sound in water 
at different temperatures are taken from literature [11]. Speed of sound is calculated following 
experimental reports by Bashkatov and Genina [12], which is valid from 0 – 100°C. Distilled 
water was pre-heated to > 80°C, and data was acquired as the water cooled down to room 
temperature. 10 consecutive Brillouin measurements were taken with 5 mW input power and ~ 
0.7 s integration time at each temperature, which was measured with a high precision 
thermometer (HH804U, Omega). Temperature drift occurred during in vivo data acquisition. To 
correct for this, we quantified the temperature-induced measurement variations within a narrower 
temperature window ranging from 20 – 30 oC (corresponding to the maximum temperature range 
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in a clinical setting), and created a lookup table containing Brillouin frequency shift of the 
reference materials at different temperatures by fitting 2nd polynomials to the data (Fig. S6b). 
The table was then used to correct the calibration data taken for each axial scan.  
 
 
 
Fig. S6: Temperature dependence of Brillouin measurements and calibration. (a). Brillouin 
frequency shift of water versus temperature with theoretical prediction. Dots: raw data; red 
dashed line: prediction. (b) Temperature dependence of Brillouin frequency shift in water and PS 
over the 20 – 30°C window for temperature correction.  
 
 
Brillouin measurement short-term and long-term stability 
 
Both short-term and long-term measurement instability may be caused by environment-induced 
light source and/or spectrometer drift, mechanical instability of the optical system, etc. To 
minimize these effects, the imaging system was calibrated daily to maintain its performance. 
Experiments were also carried out to quantify the measurement variations of the system. In 
laboratory conditions with typical temperature drift up to 1°C per hour, we characterized short 
term measurement stability through 12 consecutive measurements of the Brillouin frequency 
shift of a water sample, taken at intervals of 2.5 minutes. At each of the 12 time-points, the 
Brillouin frequency value is itself obtained from the average of 5 measurements. Averaged 
values lie within a ±5 MHz range above and below baseline (Fig. S7a). To examine day-to-day 
variation, the Brillouin frequency shift of a PMMA sample was measured over four consecutive 
days at the same time of day in the laboratory environment. 5 measurements were averaged for 
each daily Brillouin value. Measurements were obtained with 0.2 s integration time at 5 mW 
input optical power. Day-to-day variation is found to be < 10 MHz (Fig. S7b). On a longer 
timescale, Brillouin measurements of water over a 140-day period indicate that the long-term 
stability is ~ ±10 MHz (Fig. S7c).  
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Fig. S7. Measurement of short-term and long-term stability. (a) 12 measurements of water, taken 
2.5 minutes apart in the laboratory environment. Dots: mean of 5 measurements; Error bar: 
standard deviation of 5 measurements; Shadowed zone: ±5 MHz window around the baseline. 
(b) Brillouin measurements of a PMMA sample over four consecutive days, taken at the same 
time of day in the laboratory environment. Dots: mean of 5 measurements; Error bar: standard 
deviation of 5 measurements; Shadowed zone: ±5 MHz window around the base line. (c) 
Repeated Brillouin measurements of water over a 140-day period, yielding ±10 MHz long-term 
stability.  
 
 
Daily variations in in vivo Brillouin measurements 
 
We performed preliminary experiments to assess the daily variation of measurements for 
individual subjects. For this, we measured Brillouin frequency shift of 3 healthy subjects’ 
corneas over 3 consecutive days at the same time of day (around 5 o’clock pm) in a laboratory 
with no environmental (temperature, humidity) control. Before Brillouin measurements, central 
corneal thickness was measured with corneal topography. Standard deviation of CCT 
measurements of subjects 1, 2, and 3 were: 4.7, 1.0, and 5.5 µm, respectively (Fig. S8a). 5 
measurements taken in the central cornea with a radius (R) of < 1 mm from pupil center were 
averaged to obtain each daily Brillouin frequency-shift value. Standard deviation of the 
measurements from subjects 1, 2, and 3 were 0.0042, 0.0062, and 0.0169 GHz, respectively (Fig. 
S8b). Mean standard deviation of Brillouin frequency shift from the three subjects was 0.009 
GHz, which is within the sensitivity of our instrument. 
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Fig. S8. Daily variation of in vivo measurements. (a) Central corneal thickness of three healthy 
subjects over three consecutive days at 17:00, measured using corneal Scheimpflug topography. 
(b) Brillouin frequency shift measurements from the same subjects color-coded as in (a). Dots: 
average of 5 central measurements; error bars: standard deviation of the 5 central measurements.  
 
Definition of zones for analyzing spatial variation in Brillouin measurements 
To analyze the spatial variation in Brillouin values across the cornea, we define various regions 
of interest (see Fig. S9 for a graphical illustration of these zones). Central region is defined as the 
zone within a R = 1 mm radius around the pupil center; Peripheral region in contrast is the area 
with a distance R > 3 mm from the pupil center. In keratoconic corneas, the ‘cone region’ is 
defined as the area with R < 1 mm from the thinnest point (the ‘cone center’) identified with 
Scheimpflug-based corneal topographic imaging, and the ‘outside-cone region’ refers to the 
region R > 3 mm from the cone center.   
 
 
Fig. S9. Definition of zones for analyzing spatial variation. (a) Central region and the peripheral 
regions, which are defined as areas on the corneal surface within R < 1 mm and R > 3 mm, 
respectively. (b)  The ‘cone region’ and ‘outside-cone region’, defined as areas within R < 1 mm 
R > 3 mm from the ‘cone center’ that is the thinnest point identified by Scheimpflug corneal 
topography, respectively.  
 
 
Regional differences in Brillouin frequency shift measured in keratoconic corneas 
We defined annular regions extending radially outwards in 0.5 mm increments, centered on the 
cone (again specified by the thinnest point in the corneal topography). The Brillouin frequency 
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shift in the corneal stroma was averaged over the spatial extent of these annuli and then the 
difference was taken with respect to the value in the cone region (<1 mm from the thinnest 
point). Results from the normal cornea group, and KC stage I – IV groups are presented in Fig. 
S10.  
 
 
 
Fig. S10. Regional differences in Brillouin frequency shift measured in corneas. Plots show 
lateral profiles of average Brillouin frequency shift from cone center to peripheral regions in 
normal, and KC stage I – IV corneas.  
 
Safety of Brillouin measurements 
Our Brillouin system uses illumination intensity levels comparable to or less than equivalent 
ocular instruments that are already FDA-cleared and widely used in clinical practice, such as 
corneal confocal scanning microscopy and anterior-segment optical coherence tomography. The 
optical source in our Brillouin instrument emits near-infrared light at a wavelength of 780 nm. 
Exposure of human eyes to this light during our study was within safety limits established by the 
American National Standard for Safe Use of Lasers (ANSI Z136.1-2007). The ANSI standard 
indicates that exposure to 780 nm laser light at the level we use for imaging (5 mW) does not 
pose a risk to the subject if the continuous exposure does not exceed 5.75 minutes. In our study, 
the continuous exposure time for each axial scan was < 15 s. 
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